181 related articles for article (PubMed ID: 29273462)
41. Specific targeting of CD163
Etzerodt A; Tsalkitzi K; Maniecki M; Damsky W; Delfini M; Baudoin E; Moulin M; Bosenberg M; Graversen JH; Auphan-Anezin N; Moestrup SK; Lawrence T
J Exp Med; 2019 Oct; 216(10):2394-2411. PubMed ID: 31375534
[TBL] [Abstract][Full Text] [Related]
42. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
[TBL] [Abstract][Full Text] [Related]
43. Suppression of alloimmunity in mice by regulatory T cells converted with conditioned media.
Teng L; Liu L; Su Y; Yuan X; Li J; Fu Q; Chen S; Wang C
J Surg Res; 2011 Dec; 171(2):797-806. PubMed ID: 20538297
[TBL] [Abstract][Full Text] [Related]
44. Impact of inflammation-metaplasia-adenocarcinoma sequence and inflammatory microenvironment in esophageal carcinogenesis using surgical rat models.
Miyashita T; Tajima H; Shah FA; Oshima M; Makino I; Nakagawara H; Kitagawa H; Fujimura T; Harmon JW; Ohta T
Ann Surg Oncol; 2014 Jun; 21(6):2012-9. PubMed ID: 24526548
[TBL] [Abstract][Full Text] [Related]
45. Activatable near-infrared fluorescent probe for in vivo imaging of fibroblast activation protein-alpha.
Li J; Chen K; Liu H; Cheng K; Yang M; Zhang J; Cheng JD; Zhang Y; Cheng Z
Bioconjug Chem; 2012 Aug; 23(8):1704-11. PubMed ID: 22812530
[TBL] [Abstract][Full Text] [Related]
46. Targeting FAPα-expressing tumor-associated mesenchymal stromal cells inhibits triple-negative breast cancer pulmonary metastasis.
Li X; Chen M; Lu W; Tang J; Deng L; Wen Q; Huang M; Deng R; Ye G; Ye W; Zhang D
Cancer Lett; 2021 Apr; 503():32-42. PubMed ID: 33482262
[TBL] [Abstract][Full Text] [Related]
47. Anti-tumour effects of a xenogeneic fibroblast activation protein-based whole cell tumour vaccine in murine tumour models.
Chen M; Xu G; Fan M; Jia H; Xiao L; Lang J
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4182-4193. PubMed ID: 31722575
[TBL] [Abstract][Full Text] [Related]
48. Combination of a bispecific antibody and costimulatory antibody-ligand fusion proteins for targeted cancer immunotherapy.
Hornig N; Kermer V; Frey K; Diebolder P; Kontermann RE; Müller D
J Immunother; 2012 Jun; 35(5):418-29. PubMed ID: 22576347
[TBL] [Abstract][Full Text] [Related]
49. The Association of Peripheral Blood Regulatory T-Cell Concentrations With Epithelial Ovarian Cancer: A Brief Report.
Cannioto RA; Sucheston-Campbell LE; Hampras S; Goode EL; Knutson K; Ness R; Modugno F; Wallace P; Szender JB; Mayor P; Hong CC; Joseph JM; Friel G; Davis W; Nesline M; Eng KH; Edwards RP; Kruszka B; Schmitt K; Odunsi K; Moysich KB
Int J Gynecol Cancer; 2017 Jan; 27(1):11-16. PubMed ID: 27759594
[TBL] [Abstract][Full Text] [Related]
50. Contribution of regulatory T cells to cancer: A review.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):7983-7993. PubMed ID: 30317612
[TBL] [Abstract][Full Text] [Related]
51. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.
Luan YY; Yao YM; Zhang L; Dong N; Zhang QH; Yu Y; Sheng ZY
Mol Immunol; 2011 Oct; 49(1-2):219-26. PubMed ID: 21963221
[TBL] [Abstract][Full Text] [Related]
52. Fibroblast activation protein α in tumor microenvironment: recent progression and implications (review).
Zi F; He J; He D; Li Y; Yang L; Cai Z
Mol Med Rep; 2015 May; 11(5):3203-11. PubMed ID: 25593080
[TBL] [Abstract][Full Text] [Related]
53. INFα-2b inhibitory effects on CD4(+)CD25(+)FOXP3(+) regulatory T cells in the tumor microenvironment of C57BL/6 J mice with melanoma xenografts.
Yu Y; Huang R; Zong X; He X; Mo W
BMC Cancer; 2016 Jul; 16():397. PubMed ID: 27389040
[TBL] [Abstract][Full Text] [Related]
54. Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis.
Acharya PS; Zukas A; Chandan V; Katzenstein AL; Puré E
Hum Pathol; 2006 Mar; 37(3):352-60. PubMed ID: 16613331
[TBL] [Abstract][Full Text] [Related]
55. Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma.
Richendollar BG; Pohlman B; Elson P; Hsi ED
Hum Pathol; 2011 Apr; 42(4):552-7. PubMed ID: 21237493
[TBL] [Abstract][Full Text] [Related]
56. Protein Nanocage Mediated Fibroblast-Activation Protein Targeted Photoimmunotherapy To Enhance Cytotoxic T Cell Infiltration and Tumor Control.
Zhen Z; Tang W; Wang M; Zhou S; Wang H; Wu Z; Hao Z; Li Z; Liu L; Xie J
Nano Lett; 2017 Feb; 17(2):862-869. PubMed ID: 28027646
[TBL] [Abstract][Full Text] [Related]
57. Fibroblast activation protein-α promotes the growth and migration of lung cancer cells via the PI3K and sonic hedgehog pathways.
Jia J; Martin TA; Ye L; Meng L; Xia N; Jiang WG; Zhang X
Int J Mol Med; 2018 Jan; 41(1):275-283. PubMed ID: 29115573
[TBL] [Abstract][Full Text] [Related]
58. Lupus nephritis: correlation of immunohistochemical expression of C4d, CD163-positive M2c-like macrophages and Foxp3-expressing regulatory T cells with disease activity and chronicity.
Allam M; Fathy H; Allah DA; Salem MAE
Lupus; 2020 Jul; 29(8):943-953. PubMed ID: 32580679
[TBL] [Abstract][Full Text] [Related]
59. Comparison of Foxp3+ regulatory T cells and CD163+ macrophages in invasive and non-invasive extramammary Paget's disease.
Fujimura T; Kambayashi Y; Hidaka T; Hashimoto A; Haga T; Aiba S
Acta Derm Venereol; 2012 Nov; 92(6):625-8. PubMed ID: 22949100
[TBL] [Abstract][Full Text] [Related]
60. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
